 Karl Boehme
Concepts (194)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 10 | 2021 | 21 | 3.780 |
Why?
| | Reoviridae | 10 | 2018 | 25 | 2.540 |
Why?
| | Orthoreovirus, Mammalian | 5 | 2021 | 17 | 2.090 |
Why?
| | Viral Nonstructural Proteins | 5 | 2021 | 61 | 1.960 |
Why?
| | Virus Replication | 7 | 2021 | 150 | 1.750 |
Why?
| | Mammalian orthoreovirus 3 | 4 | 2021 | 11 | 1.620 |
Why?
| | Myocarditis | 2 | 2024 | 49 | 1.520 |
Why?
| | Capsid Proteins | 3 | 2021 | 24 | 1.510 |
Why?
| | Viremia | 4 | 2018 | 23 | 1.410 |
Why?
| | Fibroblasts | 7 | 2021 | 359 | 1.000 |
Why?
| | Reverse Genetics | 3 | 2017 | 5 | 1.000 |
Why?
| | Endothelial Cells | 5 | 2025 | 283 | 0.920 |
Why?
| | Interferon-beta | 5 | 2018 | 33 | 0.770 |
Why?
| | Receptors, Cell Surface | 4 | 2014 | 113 | 0.750 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2021 | 6 | 0.740 |
Why?
| | Viral Proteins | 4 | 2018 | 164 | 0.730 |
Why?
| | Interferon Type I | 2 | 2021 | 28 | 0.730 |
Why?
| | Viral Envelope Proteins | 5 | 2006 | 35 | 0.720 |
Why?
| | Mice | 15 | 2024 | 5958 | 0.720 |
Why?
| | NF-kappa B | 4 | 2018 | 329 | 0.670 |
Why?
| | Cytomegalovirus | 5 | 2008 | 30 | 0.660 |
Why?
| | Interferon Regulatory Factor-3 | 2 | 2018 | 9 | 0.640 |
Why?
| | Animals | 22 | 2025 | 13507 | 0.630 |
Why?
| | Pandemics | 1 | 2022 | 587 | 0.550 |
Why?
| | Oncolytic Viruses | 1 | 2017 | 13 | 0.540 |
Why?
| | Carcinoma, Large Cell | 1 | 2017 | 16 | 0.540 |
Why?
| | Cell Cycle Checkpoints | 2 | 2013 | 32 | 0.520 |
Why?
| | Cell Adhesion Molecules | 2 | 2014 | 88 | 0.500 |
Why?
| | Apoptosis | 3 | 2018 | 1121 | 0.450 |
Why?
| | Virulence Factors | 2 | 2013 | 80 | 0.440 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 1900 | 0.410 |
Why?
| | Animals, Newborn | 3 | 2021 | 366 | 0.410 |
Why?
| | Cells, Cultured | 7 | 2018 | 1588 | 0.370 |
Why?
| | Cell Line | 9 | 2017 | 1033 | 0.370 |
Why?
| | Cell Culture Techniques | 1 | 2011 | 99 | 0.350 |
Why?
| | RNA, Double-Stranded | 3 | 2018 | 23 | 0.340 |
Why?
| | Sindbis Virus | 2 | 2000 | 3 | 0.340 |
Why?
| | Humans | 24 | 2025 | 52593 | 0.320 |
Why?
| | HEK293 Cells | 2 | 2021 | 232 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 3 | 2008 | 24 | 0.290 |
Why?
| | Seroepidemiologic Studies | 3 | 2023 | 44 | 0.290 |
Why?
| | Antibodies, Viral | 3 | 2023 | 110 | 0.280 |
Why?
| | Cricetinae | 3 | 2018 | 193 | 0.270 |
Why?
| | Viral Load | 2 | 2021 | 80 | 0.270 |
Why?
| | Virus Diseases | 2 | 2025 | 46 | 0.270 |
Why?
| | Inflammation | 3 | 2021 | 644 | 0.270 |
Why?
| | Membrane Glycoproteins | 2 | 2004 | 242 | 0.250 |
Why?
| | Genes, Viral | 3 | 2017 | 39 | 0.250 |
Why?
| | Lymphatic System | 1 | 2025 | 12 | 0.240 |
Why?
| | Plasmids | 3 | 2017 | 167 | 0.230 |
Why?
| | Lymphatic Vessels | 1 | 2025 | 44 | 0.230 |
Why?
| | Virion | 2 | 2000 | 18 | 0.220 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 1436 | 0.210 |
Why?
| | Intestines | 3 | 2017 | 154 | 0.210 |
Why?
| | Virulence | 2 | 2021 | 167 | 0.200 |
Why?
| | Disease Models, Animal | 4 | 2024 | 1486 | 0.200 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2018 | 201 | 0.190 |
Why?
| | T-Lymphocytes | 1 | 2024 | 329 | 0.180 |
Why?
| | RNA, Viral | 2 | 2017 | 125 | 0.180 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 426 | 0.180 |
Why?
| | Culicidae | 1 | 2000 | 5 | 0.180 |
Why?
| | Signal Transduction | 3 | 2008 | 1714 | 0.180 |
Why?
| | Students | 1 | 2023 | 228 | 0.170 |
Why?
| | Autoantibodies | 1 | 2021 | 121 | 0.170 |
Why?
| | Transcription Factors | 1 | 2004 | 566 | 0.170 |
Why?
| | Enzyme Activation | 2 | 2018 | 269 | 0.160 |
Why?
| | Recombination, Genetic | 3 | 2017 | 109 | 0.160 |
Why?
| | Virus Internalization | 2 | 2018 | 20 | 0.160 |
Why?
| | Oligosaccharides | 1 | 2000 | 33 | 0.160 |
Why?
| | Arkansas | 2 | 2023 | 2029 | 0.160 |
Why?
| | RNA Interference | 2 | 2018 | 186 | 0.160 |
Why?
| | Phosphorylation | 2 | 2018 | 530 | 0.150 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 1006 | 0.150 |
Why?
| | Time Factors | 2 | 2024 | 3000 | 0.150 |
Why?
| | Genome, Viral | 2 | 2017 | 83 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2021 | 910 | 0.140 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 218 | 0.140 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 102 | 0.140 |
Why?
| | HeLa Cells | 1 | 2018 | 261 | 0.140 |
Why?
| | Glutens | 1 | 2017 | 3 | 0.140 |
Why?
| | Celiac Disease | 1 | 2017 | 8 | 0.140 |
Why?
| | Antigens | 1 | 2017 | 41 | 0.130 |
Why?
| | Reassortant Viruses | 1 | 2017 | 4 | 0.130 |
Why?
| | Th1 Cells | 1 | 2017 | 55 | 0.130 |
Why?
| | Receptors, Virus | 2 | 2014 | 26 | 0.130 |
Why?
| | Mutation | 3 | 2017 | 1344 | 0.130 |
Why?
| | Genetic Engineering | 2 | 2017 | 23 | 0.120 |
Why?
| | Cell Survival | 1 | 2017 | 602 | 0.120 |
Why?
| | Tight Junctions | 1 | 2014 | 27 | 0.110 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.110 |
Why?
| | Adolescent | 2 | 2023 | 6737 | 0.110 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 59 | 0.110 |
Why?
| | Infant | 1 | 2022 | 3720 | 0.110 |
Why?
| | Child, Preschool | 1 | 2022 | 4062 | 0.100 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 10 | 0.100 |
Why?
| | Transfection | 2 | 2011 | 369 | 0.100 |
Why?
| | Brain | 2 | 2011 | 1325 | 0.100 |
Why?
| | Respiratory Tract Infections | 1 | 2013 | 82 | 0.100 |
Why?
| | Adult | 3 | 2023 | 14170 | 0.090 |
Why?
| | Cytokines | 2 | 2006 | 626 | 0.090 |
Why?
| | Blood | 1 | 2011 | 26 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 2013 | 225 | 0.090 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 97 | 0.090 |
Why?
| | Cloning, Molecular | 1 | 2011 | 182 | 0.090 |
Why?
| | Spinal Cord | 1 | 2011 | 132 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2011 | 130 | 0.090 |
Why?
| | Rotavirus | 1 | 2010 | 9 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2012 | 380 | 0.090 |
Why?
| | Spleen | 1 | 2011 | 171 | 0.090 |
Why?
| | Antiviral Agents | 2 | 2004 | 177 | 0.080 |
Why?
| | Survival Analysis | 1 | 2011 | 673 | 0.080 |
Why?
| | Child | 1 | 2022 | 7229 | 0.080 |
Why?
| | Lung | 1 | 2013 | 501 | 0.080 |
Why?
| | Heart | 1 | 2011 | 361 | 0.080 |
Why?
| | Toll-Like Receptors | 2 | 2004 | 27 | 0.070 |
Why?
| | RNA Viruses | 1 | 2007 | 8 | 0.070 |
Why?
| | Vaccines, Synthetic | 1 | 2007 | 21 | 0.070 |
Why?
| | Viral Vaccines | 1 | 2007 | 16 | 0.070 |
Why?
| | Toll-Like Receptor 1 | 1 | 2006 | 1 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2008 | 117 | 0.070 |
Why?
| | Inflammation Mediators | 1 | 2006 | 116 | 0.060 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2006 | 49 | 0.060 |
Why?
| | Lymphangiogenesis | 1 | 2025 | 5 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1160 | 0.060 |
Why?
| | Adaptive Immunity | 1 | 2025 | 33 | 0.060 |
Why?
| | Antigens, Differentiation | 1 | 2004 | 16 | 0.060 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2004 | 34 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 36 | 0.060 |
Why?
| | CpG Islands | 1 | 2004 | 121 | 0.050 |
Why?
| | Interferon-alpha | 1 | 2004 | 52 | 0.050 |
Why?
| | Cytomegalovirus Infections | 1 | 2004 | 36 | 0.050 |
Why?
| | Lymph Nodes | 1 | 2025 | 252 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2003 | 25 | 0.050 |
Why?
| | Serologic Tests | 1 | 2022 | 25 | 0.050 |
Why?
| | Universities | 1 | 2023 | 175 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 27 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2021 | 56 | 0.040 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 58 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 574 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2000 | 44 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 773 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 747 | 0.040 |
Why?
| | Angiotensin II | 1 | 2021 | 162 | 0.040 |
Why?
| | 1-Deoxynojirimycin | 1 | 2000 | 1 | 0.040 |
Why?
| | Mannosidases | 1 | 2000 | 5 | 0.040 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2000 | 5 | 0.040 |
Why?
| | Ultracentrifugation | 1 | 2000 | 10 | 0.040 |
Why?
| | Aedes | 1 | 2000 | 10 | 0.040 |
Why?
| | CHO Cells | 1 | 2000 | 124 | 0.040 |
Why?
| | Glycosylation | 1 | 2000 | 104 | 0.040 |
Why?
| | Phenotype | 1 | 2000 | 800 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2000 | 372 | 0.030 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2017 | 14 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2017 | 91 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 1686 | 0.030 |
Why?
| | Male | 3 | 2023 | 26863 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2017 | 564 | 0.030 |
Why?
| | Female | 3 | 2023 | 28262 | 0.030 |
Why?
| | Viral Tropism | 1 | 2013 | 5 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 121 | 0.030 |
Why?
| | Tyrosine | 1 | 2013 | 91 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 37 | 0.030 |
Why?
| | Young Adult | 1 | 2023 | 4337 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2013 | 89 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 80 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 137 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 180 | 0.020 |
Why?
| | Diet | 1 | 2017 | 588 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2013 | 145 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 673 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2010 | 48 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2010 | 27 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 137 | 0.020 |
Why?
| | DNA, Viral | 1 | 2010 | 138 | 0.020 |
Why?
| | Temperature | 1 | 2010 | 165 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 134 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 637 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 496 | 0.020 |
Why?
| | Acids | 1 | 2008 | 10 | 0.020 |
Why?
| | Microsomes | 1 | 2008 | 35 | 0.020 |
Why?
| | Endosomes | 1 | 2008 | 36 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 157 | 0.020 |
Why?
| | Mammals | 1 | 2007 | 60 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2006 | 12 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 21 | 0.020 |
Why?
| | Immediate-Early Proteins | 1 | 2006 | 18 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2006 | 88 | 0.020 |
Why?
| | Cell Count | 1 | 2006 | 144 | 0.020 |
Why?
| | Antibodies | 1 | 2006 | 150 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 147 | 0.020 |
Why?
| | Trans-Activators | 1 | 2006 | 138 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 984 | 0.010 |
Why?
| | Skin | 1 | 2006 | 418 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2003 | 122 | 0.010 |
Why?
|
|
Boehme's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|